share_log

3D MEDICINES:自願性公告 就恩沃利單抗與康寧傑瑞及GLENMARK達成的許可協議

3D MEDICINES: VOLUNTARY ANNOUNCEMENT LICENSE AGREEMENT WITH ALPHAMAB AND GLENMARK FOR ENVAFOLIMAB

香港交易所 ·  Jan 24 19:01
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more